(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[5-(pyrrolidin-3-ylmethyl)-3-pyridinyl]methanone;hydrochloride
C18H24ClN5O — CID 171711105
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[5-(pyrrolidin-3-ylmethyl)-3-pyridinyl]methanone;hydrochloride
(2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[5-(pyrrolidin-3-ylmethyl)-3-pyridinyl]methanone;hydrochloride (PubChem CID 171711105) has the molecular formula C18H24ClN5O and a molecular weight of 361.88 g/mol. Its IUPAC name is (2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[5-(pyrrolidin-3-ylmethyl)-3-pyridinyl]methanone;hydrochloride.
Molecular Properties
| Compound Name | (2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[5-(pyrrolidin-3-ylmethyl)-3-pyridinyl]methanone;hydrochloride |
|---|---|
| PubChem CID | 171711105 |
| Molecular Formula | C18H24ClN5O |
| Molecular Weight | 361.88 g/mol |
| Exact Mass | 361.17 |
| IUPAC Name | (2-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[5-(pyrrolidin-3-ylmethyl)-3-pyridinyl]methanone;hydrochloride |
| SMILES | Cc1cc2n(n1)CCN(C(=O)c1cncc(CC3CCNC3)c1)C2.Cl |
| InChI | InChI=1S/C18H23N5O.ClH/c1-13-6-17-12-22(4-5-23(17)21-13)18(24)16-8-15(10-20-11-16)7-14-2-3-19-9-14;/h6,8,10-11,14,19H,2-5,7,9,12H2,1H3;1H |
| InChIKey | DWVQEPSBNOISPV-UHFFFAOYSA-N |
| XLogP | 1.82 |
| TPSA | 63.05 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 361.88 |
| LogP ≤ 5 | 1.82 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171711105 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.